Intellectual Property India Publishes Patent Application for '2-Amino-N-(4-Amino-3,4-Dioxo-1-(2-Oxopyrrolidin-3-Yl)Butan-2-Yl)Benzamide Derivatives As Protease Inhibitors For Treating Or Preventing Coronavirus Infection' Filed by Merck Sharp & Dohme Llc

MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517055936 A) filed by Merck Sharp & Dohme Llc, Rahway, U.S.A., on June 10, for '2-amino-n-(4-amino-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butan-2-yl)benzamide derivatives as protease inhibitors for treating or preventing coronavirus infection.'

Inventor(s) include Acton III, John J; Gupta, Mayuri; Kelly III, Michael J.; Klingler, Franca-Maria; Layton, Mark Eric; Mccauley, John A.; Morriello, Gregori J; Nawrat, Christopher Charles; Parish, Craig A.; Roecker, Anthony J.; De Lera Ruiz, Manuel; Su, Jing; Shurtleff, Valerie W.; and Truong, Quang T.

The application for the patent was published on July 4, under issue no. 27/2025.

According to the abstract rel...